Business
fromFortune
7 hours agoPfizer's CEO on leading after a moonshot-and making deals with Trump | Fortune
Pfizer experienced a post-COVID revenue decline and is pivoting to new moonshots like GLP-1s and cancer therapies to restore growth and resilience.